These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8136540)

  • 21. Psoriasis and vitamin D3. A review of our experience.
    Morimoto S; Yoshikawa K
    Arch Dermatol; 1989 Feb; 125(2):231-4. PubMed ID: 2536537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of vitamin D3 derivatives in the treatment of psoriasis vulgaris: a preliminary report.
    el-Azhary RA; Peters MS; Pittelkow MR; Kao PC; Muller SA
    Mayo Clin Proc; 1993 Sep; 68(9):835-41. PubMed ID: 8396699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of topical calcipotriol on calcium metabolism in psoriatic patients: comparison with oral calcitriol.
    Gumowski-Sunek D; Rizzoli R; Saurat JH
    Dermatologica; 1991; 183(4):275-9. PubMed ID: 1809590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
    Abramovits W
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
    Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis.
    Perez A; Raab R; Chen TC; Turner A; Holick MF
    Br J Dermatol; 1996 Jun; 134(6):1070-8. PubMed ID: 8763427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
    Van de Kerkhof PC; Werfel T; Haustein UF; Luger T; Czarnetzki BM; Niemann R; Plänitz-Stenzel V
    Br J Dermatol; 1996 Nov; 135(5):758-65. PubMed ID: 8977677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study.
    Langner A; Verjans H; Stapór V; Mol M; Fraczykowska M
    Br J Dermatol; 1993 May; 128(5):566-71. PubMed ID: 8504051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasis.
    Lebwohl M; Ortonne JP; Andres P; Briantais P
    Cutis; 2009 Apr; 83(4):205-12. PubMed ID: 19445311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerance of topical calcitriol 3 microg g(-1) in psoriasis treatment: a review of our experience in Poland.
    Langner A; Stapór W; Ambroziak M
    Br J Dermatol; 2001 Apr; 144 Suppl 58():11-6. PubMed ID: 11501507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of high-concentration tacalcitol ointment in psoriasis vulgaris after changing from other high-concentration vitamin D3 ointments.
    Syuto T; Ishibuchi H; Sogabe Y; Yokoyama Y; Ishikawa O
    Dermatol Online J; 2008 Feb; 14(2):2. PubMed ID: 18700105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An open-label, multicenter study of the efficacy and safety of a weekday/weekend treatment regimen with calcitriol ointment 3 microg/g and clobetasol propionate spray 0.05% in the management of plaque psoriasis.
    Hudson CP; Kempers S; Menter A; Papp K; Smith S; Sofen H; Colón LE; Johnson LA; Gottschalk R
    Cutis; 2011 Oct; 88(4):201-7. PubMed ID: 22106730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol.
    Hutchinson PE; Marks R; White J
    Dermatology; 2000; 201(2):139-45. PubMed ID: 11053917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical administration of 1,25-dihydroxyvitamin D3 for psoriasis: report of five cases.
    Morimoto S; Onishi T; Imanaka S; Yukawa H; Kozuka T; Kitano Y; Yoshikawa K; Kumahara Y
    Calcif Tissue Int; 1986 Feb; 38(2):119-22. PubMed ID: 3082494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
    Liao YH; Chiu HC; Tseng YS; Tsai TF
    Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity.
    Queille-Roussel C; Duteil L; Parneix-Spake A; Arsonnaud S; Rizova E
    Eur J Dermatol; 2001; 11(3):219-24. PubMed ID: 11358728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical calcipotriol (MC 903) for psoriasis: a clinical study.
    Mozzanica N; Cattaneo A; Schmitt E; Legori A; Finzi AF
    Acta Derm Venereol Suppl (Stockh); 1994; 186():169-70. PubMed ID: 8073826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.